Monte Rosa Therapeutics, Inc.·4

Jun 15, 4:27 PM ET

Mayweg Alexander 4

4 · Monte Rosa Therapeutics, Inc. · Filed Jun 15, 2023

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-14+20,50020,500 total
    Exercise: $6.59Exp: 2033-06-13Common Stock (20,500 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION